DNAJB1 (DnaJ Homolog Subfamily B Member 1) is a heat shock protein 40 (HSP40) family member that collaborates with HSP70 to regulate protein folding, stress responses, and disaggregation of misfolded proteins . It contains a conserved J-domain critical for ATPase activation of HSP70 and a glycine/phenylalanine-rich region for substrate binding . DNAJB1 also modulates immune responses by disrupting MDA5 oligomerization and participates in Huntington’s disease pathology by targeting polyQ-expanded huntingtin (HTT) .
A typical DNAJB1 antibody pair includes:
Primary Antibody 1: Targets the N-terminal J-domain (e.g., clone 2A7-H6, mouse monoclonal, ABIN361662) .
Primary Antibody 2: Binds the C-terminal substrate-binding region (e.g., rabbit polyclonal, 13174-1-AP) .
Parameter | Antibody 1 (ABIN361662) | Antibody 2 (13174-1-AP) |
---|---|---|
Host | Mouse | Rabbit |
Clonality | Monoclonal (Clone 2A7-H6) | Polyclonal |
Applications | WB, ELISA, IP | WB, IHC, IF, FC, IP, ELISA |
Reactivity | Yeast-specific | Human, Mouse, Rat |
Epitope | C-terminal (Full-length HSP40) | Fusion protein (AA 1–340) |
Molecular Weight | ~40 kDa | 37–40 kDa |
DNAJB1 antibody pairs validated interactions with MDA5, MAVS, and HSP70 in stress granules using proximity ligation assays (PLA) .
Co-immunoprecipitation confirmed DNAJB1’s binding to HTTExon1Q48 via a conserved HTT-binding motif (HBM) .
DNAJB1-HSP70 complexes dissociate MDA5 multimers, suppressing type I interferon induction .
Mutation of H244 in DNAJB1’s HBM abolished HTT fibril disaggregation, highlighting specificity for amyloid remodeling .
DNAJB1 knockout cells (generated via CRISPR-Cas9) showed enhanced MDA5/MAVS-mediated antiviral responses .
In Huntington’s disease models, DNAJB1 antibody pairs detected colocalization with HTT aggregates in HEK293 cells .
DNAJB1 (DnaJ Heat Shock Protein Family Member B1) is a critical molecular chaperone characterized by a highly conserved J-domain. It functions as one of the two major classes of molecular chaperones involved in protein folding and oligomeric protein complex assembly. DNAJB1 specifically stimulates the ATPase activity of Hsp70 heat-shock proteins to promote proper protein folding and prevent misfolded protein aggregation . The protein has a calculated molecular weight of approximately 38-40 kDa, though the observed molecular weight on Western blots may vary due to post-translational modifications . DNAJB1 is particularly interesting to researchers studying cellular stress responses, protein quality control mechanisms, and various pathologies involving protein misfolding.
When selecting DNAJB1 antibodies, researchers should consider several critical factors based on their experimental needs. First, evaluate species reactivity; available antibodies demonstrate varying cross-reactivity patterns ranging from species-specific (such as yeast-specific antibodies that don't cross-react with human, mouse, or rat samples) to broadly reactive antibodies (recognizing DNAJB1 across multiple species including human, mouse, rat, and others) . Second, consider the application compatibility - some antibodies are validated for multiple techniques including Western blotting, immunohistochemistry, immunofluorescence, and immunoprecipitation, while others may have more limited applications . Third, assess the specific epitope recognition - antibodies targeting different regions (N-terminal, C-terminal, or full-length protein) may yield different results depending on protein conformation, interactions, or modifications in your experimental system . Fourth, evaluate clonality - monoclonal antibodies offer high specificity for a single epitope, while polyclonal antibodies may provide stronger signals by recognizing multiple epitopes .
Proper antibody validation is crucial for experimental reproducibility. Knockout (KO) validated antibodies provide the highest level of confidence in specificity, as demonstrated by the absence of signal in DNAJB1 knockout samples . When KO validation isn't available, researchers should conduct their own validation through multiple methods. Western blotting should show bands at the expected molecular weight (~38-40 kDa for DNAJB1), though it's important to note that observed band size may not always match calculated size due to post-translational modifications or other factors affecting protein mobility . Secondary validation through an orthogonal method (such as immunofluorescence showing expected subcellular localization patterns) further increases confidence. DNAJB1 typically localizes to both cytoplasm and nucleus, with rapid translocation to the nucleus, especially nucleoli, upon heat shock . Researchers should be particularly cautious when the experimental outcome depends on distinguishing between closely related DNAJ family members, as these share significant sequence homology.
For optimal DNAJB1 sandwich ELISA performance, the capture and detection antibodies must recognize non-overlapping epitopes. Based on available DNAJB1 antibodies, a combination of antibodies targeting N-terminal and C-terminal regions would be ideal . The capture antibody should be diluted to 1-10 μg/mL in carbonate buffer (pH 9.6) and coated overnight at 4°C. After blocking with 1-5% BSA in PBS-T (PBS with 0.05% Tween-20), add samples and standards, followed by the detection antibody at approximately 1:500-1:2000 dilution . For maximum sensitivity, consider using a detection antibody from a different host species than the capture antibody to minimize background signal. The optimal sample preparation typically involves cell lysis in a buffer containing 1% NP-40 or Triton X-100, 150mM NaCl, 50mM Tris-HCl (pH 7.4), and protease inhibitors, followed by centrifugation to remove cellular debris. Always include positive controls (recombinant DNAJB1) and negative controls to establish assay specificity.
Successful immunofluorescence with DNAJB1 antibodies requires careful optimization of several parameters. Fixation method significantly impacts epitope preservation - while 4% paraformaldehyde (10-15 minutes at room temperature) works well for most applications, methanol fixation (-20°C for 10 minutes) may better preserve certain epitopes . Permeabilization should be gentle, typically using 0.1-0.3% Triton X-100 for 5-10 minutes. Antibody dilution ranges from 1:50-1:200 for most DNAJB1 antibodies in immunofluorescence applications . When studying the stress-dependent translocation of DNAJB1, timing is critical - following heat shock, rapid fixation is necessary as DNAJB1 relocalization occurs within minutes. To distinguish between cytoplasmic and nuclear localization, counterstaining with DAPI is essential, while additional markers for nucleoli (such as fibrillarin antibodies) can help confirm the specific nucleolar accumulation pattern characteristic of DNAJB1 during stress response . For multi-color imaging, careful selection of secondary antibodies with minimal spectral overlap is necessary to avoid bleed-through artifacts.
Western blotting for DNAJB1 requires specific protocol adjustments depending on sample type. For cellular extracts, complete protein denaturation is essential - use sample buffer containing 2% SDS and 5% β-mercaptoethanol with heating at 95°C for 5 minutes. When analyzing tissue samples, more stringent homogenization in RIPA buffer containing protease inhibitors is recommended to ensure complete extraction. Protein separation should be performed on 10-12% SDS-PAGE gels to achieve optimal resolution around the 38-40 kDa range where DNAJB1 is expected . For transfer, a semi-dry transfer system using PVDF membranes typically yields better results than nitrocellulose for DNAJB1 detection. Blocking with 5% non-fat dry milk in TBS-T is generally effective, though for phospho-specific DNAJB1 detection, 5% BSA is preferred. Most DNAJB1 antibodies perform optimally at dilutions between 1:500-1:2000 . Extended primary antibody incubation (overnight at 4°C) typically produces cleaner results than shorter incubations at room temperature. For challenging samples with low DNAJB1 expression, signal enhancement systems or more sensitive detection methods such as chemiluminescence with extended exposure may be necessary.
Non-specific binding with DNAJB1 antibodies can be addressed through several systematic approaches. First, implement more stringent blocking conditions by increasing blocking agent concentration to 5-10% and extending blocking time to 2 hours at room temperature. Second, optimize antibody dilution through careful titration experiments - for polyclonal antibodies, increasing dilution to 1:1000-1:2000 often reduces background while maintaining specific signal . Third, increase wash stringency by adding 0.1-0.2% SDS to wash buffers for Western blotting or increasing wash duration for immunofluorescence applications. Fourth, pre-absorb polyclonal antibodies with tissues or cell lysates from species not expressing the target protein to remove cross-reactive antibodies. Fifth, for critical experiments, consider using knockout-validated antibodies that have demonstrated specificity through genetic validation . Finally, include appropriate negative controls in each experiment, such as secondary antibody-only controls and isotype controls for monoclonal antibodies. If non-specific binding persists despite these measures, consider alternative antibody clones or manufacturers.
Variations in DNAJB1 band size require careful interpretation within the appropriate context. First, understand that while the calculated molecular weight of DNAJB1 is approximately 38-40 kDa, the observed size may differ due to several factors . Post-translational modifications, particularly phosphorylation, can cause significant mobility shifts. DNAJB1 undergoes stress-induced phosphorylation that may result in bands of higher apparent molecular weight. Second, alternative splicing events can generate DNAJB1 isoforms of different sizes . Third, incomplete denaturation can result in persistent structural elements or protein-protein interactions that alter mobility. To distinguish between these possibilities, researchers should: (1) compare results with positive controls using recombinant DNAJB1, (2) perform dephosphorylation experiments using lambda phosphatase to determine if shifted bands revert to expected size, (3) validate observations using antibodies targeting different epitopes of DNAJB1, and (4) consider performing mass spectrometry analysis for definitive identification of bands. Remember that species differences may also contribute to size variations, so always use appropriate species-specific positive controls .
Contradictory results between detection methods require systematic troubleshooting approaches. First, evaluate the epitope accessibility in different techniques - certain epitopes may be masked in native conditions (immunoprecipitation) but accessible in denatured states (Western blotting). Second, compare antibody performance across different applications - some antibodies perform well in Western blotting but poorly in immunohistochemistry due to differences in epitope presentation . Third, consider fixation artifacts in immunohistochemistry or immunofluorescence that may alter epitope recognition. Fourth, examine buffer compatibility issues - certain buffer components may interfere with antibody binding in specific applications. To resolve contradictions, implement these strategies: (1) validate results using multiple antibodies targeting different regions of DNAJB1, (2) confirm protein identity through mass spectrometry, (3) validate antibody specificity using recombinant protein or knockout samples , (4) adjust experimental conditions to better preserve native protein structure when necessary, and (5) consider the biological context - stress conditions dramatically alter DNAJB1 localization and possibly its conformational state . When publishing contradictory results, clearly document all experimental conditions to enable proper interpretation by the scientific community.
DNAJB1 antibody pairs offer powerful tools for investigating the complex dynamics of stress-induced protein translocation. To effectively study this phenomenon, researchers should implement dual-labeling immunofluorescence approaches using antibodies targeting different epitopes of DNAJB1 . Time-course experiments are critical - fix cells at precisely timed intervals (0, 5, 15, 30, 60 minutes) following stress induction (typically 42°C heat shock). For quantitative analysis, high-content imaging systems can track the nuclear/cytoplasmic ratio of DNAJB1 signal across thousands of individual cells, generating statistically robust translocation kinetics. Advanced researchers can implement fluorescence recovery after photobleaching (FRAP) using fluorescently-tagged antibody fragments to measure the real-time mobility of DNAJB1 during stress response. Alternatively, proximity ligation assays (PLA) using antibody pairs can reveal stress-dependent interactions between DNAJB1 and partner proteins like HSP70. For in vivo studies, tissue-specific analysis of DNAJB1 translocation in response to physiological stress requires careful timing of tissue collection and immediate fixation to preserve the transient translocation patterns. These approaches collectively enable researchers to dissect the molecular mechanisms governing DNAJB1's role in cellular stress adaptation.
Investigating DNAJB1's role in protein quality control networks requires sophisticated methodological approaches. Researchers should implement co-immunoprecipitation studies using well-validated DNAJB1 antibodies coupled with mass spectrometry to identify the complete interactome under different cellular conditions. Sequential immunoprecipitation with antibodies targeting different epitopes can isolate specific subcomplexes. For functional studies, combine siRNA knockdown of DNAJB1 with pulse-chase analysis using radiolabeled amino acids to track the fate of newly synthesized proteins, revealing DNAJB1's impact on protein maturation kinetics. Proximity-dependent biotin labeling (BioID) using DNAJB1 as bait can identify transient interaction partners in living cells. For structural insights, immunoprecipitated DNAJB1 complexes can be analyzed by negative-stain electron microscopy to visualize chaperone-substrate assemblies. Advanced researchers should consider applying these techniques to patient-derived cells harboring protein-folding disease mutations to assess how DNAJB1-dependent quality control processes respond to pathological conditions. When analyzing results, it's crucial to distinguish between direct DNAJB1 effects and secondary consequences of disrupting the broader chaperone network, typically requiring careful controls and complementary approaches.
Differentiating between DNAJB1 and other closely related DNAJ family members requires sophisticated experimental design due to high sequence homology. Researchers should first perform in silico analysis to identify unique epitopes in the less conserved regions outside the J-domain. Antibodies targeting these regions should undergo rigorous validation using overexpression systems with each DNAJ family member to confirm specificity . For detection at the protein level, high-resolution techniques such as 2D gel electrophoresis followed by Western blotting can separate closely related family members based on subtle differences in isoelectric points. At the transcript level, design primers targeting unique 3' UTR regions for RT-qPCR analysis. For immunohistochemistry applications, sequential immunostaining with different DNAJ antibodies followed by spectral unmixing can reveal distinct localization patterns. When absolute specificity is required, consider using CRISPR/Cas9 knockout cells as negative controls for each family member. For functional studies, complement genetic knockdown with rescue experiments using family members from distantly related species that retain function but have divergent epitopes. When publishing, clearly document all validation steps performed to demonstrate antibody specificity across the DNAJ family to ensure reproducibility by other researchers.
Post-translational modifications (PTMs) of DNAJB1 significantly impact antibody recognition and experimental outcomes. DNAJB1 undergoes several modifications including phosphorylation, acetylation, and SUMOylation, particularly during stress responses. These modifications can mask epitopes, create new ones, or alter protein conformations, directly affecting antibody binding. When designing experiments, researchers should consider modification-sensitive and modification-insensitive antibodies . For phosphorylation studies, phospho-specific antibodies may be necessary, though they are not commonly available commercially for DNAJB1. When analyzing stress-responsive samples, researchers should be aware that heat shock dramatically alters the modification profile of DNAJB1, potentially changing antibody reactivity patterns. To address these challenges, implement parallel approaches: (1) use multiple antibodies targeting different epitopes to ensure detection regardless of modification state, (2) treat samples with appropriate enzymes (phosphatases, deacetylases) to remove specific modifications before analysis, and (3) employ 2D gel electrophoresis to separate different modified forms prior to immunoblotting. For critical experiments, mass spectrometry analysis of immunoprecipitated DNAJB1 can definitively identify the specific modified forms being detected by your antibody.
Designing DNAJB1 antibody-based assays for different cellular compartments requires careful consideration of several factors. DNAJB1 dynamically shuttles between cytoplasm, nucleus, and nucleolus during stress responses, with each compartment presenting unique challenges . For nuclear/nucleolar detection, fixation method critically impacts results - paraformaldehyde typically preserves nuclear architecture better than methanol fixation. When fractionating cells for biochemical analysis, use gentle lysis conditions (0.1% NP-40) to preserve nuclear integrity before nuclear extraction. For immunofluorescence applications, confocal microscopy with Z-stack acquisition is essential to accurately distinguish between cytoplasmic and nuclear signals. Co-staining with compartment-specific markers (lamin B for nuclear envelope, fibrillarin for nucleoli, etc.) provides necessary context for localization studies. When quantifying DNAJB1 distribution, automated image analysis algorithms should be trained to recognize cellular compartments using these markers rather than arbitrary intensity thresholds. For challenging applications like detecting DNAJB1 in membrane-associated fractions, consider using membrane-permeabilizing fixatives like Triton X-100 during sample preparation. Remember that stress conditions dramatically alter DNAJB1 distribution, so precise experimental timing and consistent environmental conditions are crucial for reproducibility .
Studying DNAJB1-mediated protein-protein interactions requires sophisticated methodological approaches tailored to capture both stable and transient interactions. For core technique selection, co-immunoprecipitation using well-validated DNAJB1 antibodies provides a solid foundation , particularly when coupled with stringent washing conditions to eliminate non-specific binding. To capture more transient interactions, implement crosslinking approaches before immunoprecipitation using membrane-permeable crosslinkers like DSP (dithiobis[succinimidyl propionate]). For in situ visualization of interactions, proximity ligation assay (PLA) using validated antibody pairs offers single-molecule resolution of protein complexes within their native cellular context. When studying the critical DNAJB1-HSP70 interaction, FRET (Förster Resonance Energy Transfer) analysis using fluorescently-labeled antibodies can reveal the dynamics of complex formation and dissociation in living cells. For high-throughput interaction screening, consider antibody-based protein arrays probed with recombinant DNAJB1. To distinguish direct from indirect interactions, complement cellular studies with in vitro binding assays using purified components. For all approaches, include appropriate controls including DNAJB1 knockout samples , J-domain mutants that disrupt specific interactions, and competitive peptide inhibitors to confirm specificity. Analysis should account for the dramatic reorganization of the DNAJB1 interactome during stress conditions, requiring carefully timed experimental designs.